Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed.

Monoclonal antibody L4F3 reacts with most acute myeloid leukemia (AML) cells and virtually all normal granulocyte/monocyte colony-forming cells (CFU-GM). Our objective was to determine whether lysis of AML cells with L4F3 and complement allowed expression of normal myeloid progenitors. The five gluc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bernstein, I D, Singer, J W, Andrews, R G, Keating, A, Powell, J S, Bjornson, B H, Cuttner, J, Najfeld, V, Reaman, G, Raskind, W
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1987
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC424297/
https://ncbi.nlm.nih.gov/pubmed/3470307
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak